Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01568 |
| Species: | Homo sapiens |
| Position : | chr5:58919038-58919746 |
| Year: | 2025 |
| Title: | BTSCs exosomes derived NamiRNA-enhancer network of miR-151a-3p mediates a positive feedback loop and promotes the progression of glioma via FAK phosphorylation |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | glioblastoma |
| PMID: | 40067892 |
| MONDO: | MONDO:0005142 |
| Tissue: | Brain |
| Tissue Ontology ID: | UBERON:0000955 |
| Cell Source: | U251 glioma cells |
| CVCL ID: | CVCL_0021 |
| Cell Type: | glioblastoma cell |
| Cell Ontology ID: | CL:0000127 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | RNA-seq |
| Low Throughput Method: | Luciferase reporter assay, CRISPR knockout, RT-RT-qPCR, Western blot |
| Target gene : | PDE4D |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01569 | chr5:58919038-58919746 | Embryonic Kidney | embryonic kidney cell | -- |